Combined Low-Dose Acetylsalicylic Acid and Dihydroergotamine in Migraine Prophylaxis: A Double-Blind, Placebo-Controlled Crossover Study

Cephalalgia

Volumn 8, Issue 3, 1988, Pages 187-192

  Bousser, Marie Germaine ^a   Soisson, Thierry ^a   Chick, Jacques ^b   Thevenet, Robert ^b   Fuseau, Eliane ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Laboratoire Millot Solac ^*  (France)

^c NONE   (France)

Author keywords

Acetylsalicylic acid; dihydroergotamine; migraine

Indexed keywords

ACETYLSALICYLIC ACID; DIHYDROERGOTAMINE;

ABDOMINAL DISTENSION; ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; MIGRAINE; ORAL DRUG ADMINISTRATION; SOMNOLENCE; STOMACH PAIN;

ADOLESCENT; ADULT; AGED; ASPIRIN; DIHYDROERGOTAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMAN; MALE; MIDDLE AGE; MIGRAINE; PLACEBOS;

EID: 0023739893     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1988.0803187.x     Document Type: Article

References (33)

1. Couch JR Hassanein FR. Platelet aggregability in migraine. Neurology 1977; 27: 843–8.
2. Deshmukh SV Meyer JS Mouche RJ. Platelet dysfunction in migraine: effect of self medication with aspirin. Thrombos Haemost 1976; 36: 319–24.
3. Deshmukh SV Meyer JS. Cyclic changes in platelet dynamics and the pathogenesis and prophylaxis of migraine. Headache 1977; 17: 101–8.
4. Hanington E Jones RJ. Migraine: a platelet disorder. Lancet 1981; 2: 720–3.
5. D'Andrea G Toldo M Cortelazzo S Ferro-Milone F. Platelet activity in migraine. Headache 1982; 22: 207–12.
6. D'Andrea G Toldo M Cananzi A Ferro-Milone F. Study of platelet activation in migraine. Control by low doses of aspirin. Stroke 1984; 15: 271–5.
7. O'Neil BP Mann JD. Aspirin prophylaxis in migraine. Lancet 1978; 2: 1179–81.
8. Masel BE Chesson AL Peters BH Levin HS Alperin JB. Platelet antagonists in migraine prophylaxis. A clinical trial using aspirin and dipyridamole. Headache 1980; 20: 13–18.
9. Moeller HC. Langzeit prophylaxe der migräne mit acetylsalicylsäure. Med Klin 1983; 78: 201–4.
10. Hosman-Benjaminse SL Bolhuis PA. Migraine and platelet aggregation in patients treated with low dose acetylsalicylic acid. Headache 1986; 26: 282–4.
11. Spuhler O. dihydroergotamine (DHE 45) als sympathicolyticum in der inneren Medizin. Schweiz Meal Wochenschr 1946; 76: 125–7.
12. Kallos P Kallos-Deffner L. The use of ergot derivatives in prophylaxis and therapy of migraine. Prog Allergy 1952; 3: 485–99.
13. Arnal J. Cent cas de migraine traitées par la DHE pendant un mois à 10 ans. Gaz Med Fr 1979; 86: 164–8.
14. Girard M. Action de la dihydroergotamine utilisée seule dans la prevention de la migraine. J Med Lyon 1969; 50: 1–15.
15. Heyck H. Prophylactic treatment of migraine with ergot compounds. In: Dallesio DJ Dalsgaard-Nielsen T Diamond S. Proceedings of the international headache symposium. Vol 1. Basel: Sandoz 1971: 99–101.
16. Zekert F Schemper M Neumann K. Acetylsalicylic acid in combination with dihydroergotamine for preventing thromboembolism. Haemostasis 1982; 11: 149–53.
17. Boismare F Richard O. Etude des effets de l'association d'aspirine et de dihydroergotamine sur les contractures de la carotide de lapin provoquées par la noradrenaline ou la serotonine. 1986. Paper available from Jacques Chick, Laboratoire Millot-Solac, 16 avenue George V, 75008 Paris, France.
18. Hanley SP Bevan J Cockbill SR Heptinstall S. Differential inhibition by low dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis. Lancet 1981; 1: 969–71.
19. Jakubowski JA Stampfer MJ Vaillancourt R Faigel D Deykin D. Low-dose enteric-coated aspirin: A practical approach to continuous-release low-dose aspirin and presystemic acetylation of human platelet cyclooxygenase. J Lab Clin Med 1986; 108: 616–21.
20. Ad Hoc Committee on Classification of Headache. JAMA 1962; 179: 717–8.
21. Bousser MG Baron JC. Drug trials in migraine. The clinician's view on end points. Neuroepidemiology 1987; 6: 228–33.
22. Hills M Armitage P. The two period cross over clinical trial. Br J Clin Pharmacol 1979; 8: 7–20.
23. Smith M Jerusalem F Rhyner K Isler H. Salicylate prophylaxis in migraine. Arch Suisses Neurol Neurochir Psych 1984; 135: 273–5.
24. Aylward M Chazot G Maddock J. Schott B. Le traitement des migraines matinales. Correlation clinique et biocinétique d'une dihydroergotamine h libération programmée. Presse Med 1984; 13: 1617–9.
25. Jorgensen RS. BC 105, et nyt migräenemittel (BC 105 ein neues Migränemittel). Ugeskr Laeg 1972; 134: 2266–8.
26. Neumann M Demarez JP Harmey JL Le Bastard B Cauquil J. Prévention des crises migraineuses par la dihydroergotamine. Etude en double aveugle contre placebo. Vie Med 1984; 65: 869–70.
27. Martucci N Manna V Mattesi P Troiani G Manzoni C Lanfranchi M. Ergot derivatives in the prophylaxis of migraine: a multicentric study with a timed-release dihydroergotamine formulation. Cephalalgia 1983; 3(suppl 1):151–5.
28. Lindblad B Bergquist D Hedner U. The effect of dihydroergotamine on the haemostatic system. Thromb Haemost 1985; 50(1):67.
29. Thebault JJ. Study of interactions between aspirin and dihydroergotamine on platelet aggregability in normal healthy volunteers. 1986. Paper available from Jacques Chick, Laboratoire Millot-Solac, 16 avenue George V, 75008 Paris, France.
30. De Metz JE Van Zwieten PA. Differential effects of dihydroergotamine on the circulatory actions of arterial and venous dilators in the rat. J Cardiovasc Pharm 1981; 3: 217–27.
31. Sinzinger H. The effect of dihydroergotamine on various platelet function tests and venous prostacyclin formation in men. Thromb Haemost 1985; 53: 285–6.
32. Pradalier A Kerdelhue B Dry J. Beta-endorphine et dihydroergotamine au cours de la migraine. Therapie 1984; 39: 323–32.
33. Romiti A Martelletti P Gallo MF Perrotta RA Giacovazzo M. Nuovi contributi su le preove di estinzione nelle cefalee essenziali. I. II test con acetilsalicilato di lisina. Boll Soc Ital Biol Sper 1983; 59(8):1130–3.